Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers

Drug Abuse Clinical Trial

— CASA  

Official title:

Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00685620
• Other study ID #: BPR010213-01
• Status: Completed
• Phase: Phase 4
• First received: May 23, 2008
• Last updated: January 10, 2017
• Start date: August 2002
• Est. completion date: February 2007

Study information

• Verified date: May 2008
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

Purpose of the project is to examine the effectiveness of Reinforcement-Based Treatment (RBT) on drug abuse and psychosocial outcomes of iner city opiate abusers who have recently completed a brief detoxification.

Description:

Participants are randomized into one of 3-groups: 1) those receiving intensive behavioral therapy plus abstinence-contingent housing, 2) those receiving recovery housing alone, and 3) those receiving standard care (referrals to community providers). For the two groups receiving recovery housing, rent payment is provided for a period of 3 months, as long as the participant remains drug-free.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 463
• Est. completion date: February 2007
• Est. primary completion date: February 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• opiate dependent agree to live in recovery housing

Exclusion Criteria:

• acute psychiatric disorder pregnant over 65

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Drug Abuse
• Substance-Related Disorders

Intervention

Behavioral:
• Reinforcement Based Treatment
3 group random assignment to receive standard care, recovery housing alone, or recovery housing plus behavioral treatment

Locations

Country	Name	City	State
United States	Johns Hopkins Bayview	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Drug abstinence at follow-up		1, 3 and 6 months	No
Secondary	Rates of employment		1, 3, and 6 months	No